NSE/BODALCHEM

BODALCHEMBODALCHEM

NSE Equity · NSE

₹67.75+1.79%

52-wk low52-WEEK RANGE52-wk high

₹43.45+55.9% from low ·-13.9% from high₹78.66

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

BODALCHEM+15.97% · 1Y

Range high ₹81.49Range low ₹42.81Latest ₹67.75252 bars · daily-close · NSE bhavcopy + 10Y history

NSE EquitySpecialty ChemicalsSmallcapLow Risk

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite50/100

Performance

Medium

Middle-of-the-pack performance.

· 52w return -2.5% — underperformer
· Trades 16.8% above 200-DMA — uptrend intact

Valuation

Low

Appears to be fairly valued to cheap vs peers.

· P/E 28.4 close to sector median 24.8
· P/B 0.78 below sector median 2.26

Growth

Medium

Steady but not standout growth.

· Revenue YoY +25.1% — strong top-line
· Profit YoY +186.0% — strong earnings growth

Profitability

Low

Profitability is a concern.

· ROE 2.7% — weak returns on equity
· Net margin 1.1% — thin margins

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeC(59/100)

Durability

43/100

Mixed quality signals; requires deeper due diligence.

Show 2 drivers

Debt/Equity0.77 (66pt)
ROE2.7% (11pt)

Valuation

69/100

Fairly priced — not a bargain, not stretched.

Show 3 drivers

P/E vs sector (28.4 / 24.8)115% (51pt)
P/B0.78 (100pt)
EV/EBITDA10.8 (70pt)

Momentum

66/100

Constructive setup — momentum building, not extended.

Show 5 drivers

52w change-2.5% (42pt)
DMA-trend alignmentup (75pt)
RSI (14)74.4 (65pt)
Price vs 200-DMA+14.1% (88pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)28.45

FAIR

CheapestP/E 28.4 near sector median.Most expensive

P/B0.78

UNDERVALUED

CheapestP/B 0.78 at 13th %ile of sector.Most expensive

EV/EBITDA10.83

FAIR

Monthly seasonality

Avg monthly return over 10 years · historical — not a forecast

Best: Apr +10.14% · Worst: Feb -4.78%

Jan

-3.7%

20% win

Feb

-4.8%

20% win

Mar

+0.4%

50% win

Apr

+10.1%

70% win

May

-0.4%

40% win

Jun

+4.5%

Monthly return distribution

Distribution of 120 monthly returns

Mean

+0.49%

Median

-2.25%

Std dev

12.20%

Best

+36.0%

Worst

-39.3%

% positive

38%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 0

No standout strengths in the current snapshot

WEAKNESSES · 1

Low return on equity (2.7%)
Below 10% ROE suggests inefficient use of shareholder capital

OPPORTUNITIES · 0

No strong near-term catalysts visible

THREATS · 1

Net debt is 97% of market cap
Financing costs become material in rising-rate regimes

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

+1.8%

+4.6%

+55.9%

+34.6%

+9.6%

+9.7%

+4.0%

-5.3%

10Y

-1.8%

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
BODALCHEMTHIS Bodal Chemicals Limited	₹67.75	-2.5%	860	28.4	0.78	2.7%	0.77	+25.1%
ABCAPITAL Aditya Birla Capital Limited	₹340.4	+68.1%	89,888	25.8	2.79	10.8%	4.60	+17.6%
ABBOTINDIA Abbott India Limited	₹25,785	-16.6%	54,547	35.8	13.60	38.0%	0.04	+9.6%
360ONE 360 ONE WAM LIMITED	₹1,113.3	+16.7%	44,744	38.7	4.77	12.3%	1.47	+35.0%
3MINDIA 3M India Limited	₹31,410	+4.4%	35,158	92.9	21.83	23.5%	0.06	+6.1%
AADHARHFC Aadhar Housing Finance Limited	₹496.45	+3.5%	21,173	20.8	3.05	14.6%	2.55	—
ABDL Allied Blenders and Distillers Limited	₹573.8	+76.4%	16,176	60.4	10.70	17.7%	0.67	+5.8%
AAVAS Aavas Financiers Limited	₹1,347.9	-37.8%	10,612	17.1	2.26	13.3%	3.08	+13.3%
63MOONS 63 moons technologies limited	₹662.7	-9.8%	8,006	—	0.92	-0.2%	0.00	-6.3%

ASK AXEL

Dig deeper into BODALCHEM

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for BODALCHEM — all in one sourced reply.

Ask free in chat

Run these tools on BODALCHEM

Historical return →

"If I had bought BODALCHEM in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on BODALCHEM

Brokerage + charges →

All-in cost for trading BODALCHEM

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Date	Amount
2023-09-22	₹0.10
2022-09-22	₹0.80
2021-09-16	₹0.80
2020-02-18	₹0.80
2019-09-12	₹0.80
2018-09-06	₹0.80
2017-09-14	₹0.50
2016-08-11	₹0.30

BODALCHEMBODALCHEM

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Peer comparison · Other

Ask Axel about BODALCHEM

Recent news

Dig deeper into BODALCHEM

Run these tools on BODALCHEM

Technical snapshot

Dividends + splits history

Stock scorecard

SWOT analysis

Recent news

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Fundamentals

Pros and cons

Sector-relative context

Company + balance sheet snapshot

Peer comparison · Other